¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Leukemia Inhibitory Factor Receptor alpha Subunit"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
granulocytic leukemia
°ú¸³±¸¹éÇ÷º´
hairy cell leukemia
Åм¼Æ÷¹éÇ÷º´
leukemia
¹éÇ÷º´
leukemia cutis
ÇǺιéÇ÷º´
leukopenic leukemia
¹éÇ÷±¸°¨¼Ò¹éÇ÷º´
lymphatic leukemia
¸²ÇÁ¼º¹éÇ÷º´
lymphoblastic leukemia
¸²ÇÁ¸ð±¸¹éÇ÷º´
lymphocytic leukemia
¸²ÇÁ±¸¹éÇ÷º´
lymphosarcoma cell leukemia
¸²ÇÁÀ°Á¾¼¼Æ÷¹éÇ÷º´
monocytic leukemia
´ÜÇÙ±¸¹éÇ÷º´
monomyelogenous leukemia
´ÜÇÙ±¸°ñ¼ö¹éÇ÷º´
myeloblastic leukemia
°ñ¼ö¸ð±¸¹éÇ÷º´
myelogenous leukemia
°ñ¼ö¼º¹éÇ÷º´
myelomonocytic leukemia
°ñ¼ö´ÜÇÙ±¸¹éÇ÷º´
megakaryocytic leukemia
°Å´ëÇÙ¼¼Æ÷¹éÇ÷º´, °ÅÇÙ±¸¹éÇ÷º´
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
monomyelogenous leukemia
´ÜÇÙ±¸°ñ¼ö¹éÇ÷º´
myeloblastic leukemia
°ñ¼ö¸ð±¸¹éÇ÷º´
myelogenous leukemia
°ñ¼ö¹éÇ÷º´
myelomonocytic leukemia
°ñ¼ö´ÜÇÙ±¸¹éÇ÷º´
promyelocytic leukemia
Àü°ñ¼ö±¸¹éÇ÷º´, Dz°ñ¼ö¼¼Æ÷¹éÇ÷º´
stem cell leukemia
(¢¡acute undifferentiated leukemia) ±Þ¼º¹ÌºÐȹéÇ÷º´
subleukemic leukemia
(¢¡aleukemic leukemia) ¹«¹éÇ÷¼º¹éÇ÷º´
adrenergic receptor
¾Æµå·¹³¯¸°¼ö¿ëü
androgen receptor
¾Èµå·Î°Õ¼ö¿ëü
antigen receptor
Ç׿ø¼ö¿ëü
antigen binding receptor
Ç׿ø°áÇÕ¼ö¿ëü
receptor autoradiography
¼ö¿ëüÀÚ°¡¹æ»ç¼±¼ú
beta-adrenergic receptor kinase
º£Å¸¾Æµå·¹³¯¸°¼º¼ö¿ëüÀλêÈÈ¿¼Ò
receptor binding
¼ö¿ëü°áÇÕ
receptor blocker
¼ö¿ëüÂ÷´ÜÁ¦
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
antigen, thymus-leukemia
Èä¼±-¹éÇ÷º´Ç׿ø, TLÇ׿ø
giant cell leukemia
°Å¼¼Æ÷¹éÇ÷º´.
hairy cell leukemia
¸ð¹ß»ó¼¼Æ÷¹éÇ÷º´
hairy cell leukemia
¸ð¹ß»ó¼¼Æ÷¹éÇ÷º´, Åм¼Æ÷¹éÇ÷º´
hairy cell leukemia
Åм¼Æ÷ ¹éÇ÷º´
hairy cell leukemia
¸ð¹ß»ó¼¼Æ÷ ¹éÇ÷º´
hairy-cell leukemia
¸ð¹ß»ó¼¼Æ÷¹éÇ÷º´
human T cell leukemia virus type I
Á¦1Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
human T cell leukemia virus type I
Á¦1Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
human T cell leukemia virus type II
Á¦2Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
human T cell leukemia virus type II
Á¦2Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
human t-cell leukemia virus
ÀÎü T¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
plasma cell leukemia
ÇüÁú¼¼Æ÷¼º ¹éÇ÷º´
plasma cell leukemia
ÇüÁú¼¼Æ÷¼º ¹éÇ÷º´(û¡òõá¬øààõ ÛÜúìÜ»)
plasma cell leukemia
ÇüÁú¼¼Æ÷ ¹éÇ÷º´
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
alpha (¥á) chain
¾ËÆÄ»ç½½, ¾ËÆÄ¼â
alpha (¥á) chain disease
¾ËÆÄ»ç½½º´, ¾ËÆÄ¼âº´
alpha (¥á) globulin
¾ËÆÄ±Û·ÎºÒ¸°
alpha (¥á)-interferon
¾ËÆÄÀÎÅÍÆä·Ð
alpha amylase
¾ËÆÄ¾Æ¹Ð¶ó¾ÆÁ¦.
alpha angle
¾ËÆÄ°¢.
alpha antitrypsin deficiency panniculitis
¾ËÆÄ Çׯ®¸³½Å°áÇÌÁö¹æÃþ¿°
alpha behavior
¾ËÆÄÇàÀ§
alpha blocking
¾ËÆÄÂ÷´Ü
alpha cell
¾ËÆÄ¼¼Æ÷
alpha cell
¾ËÆÄ¼¼Æ÷(¡á¬øà)
alpha cell glucagon cell
¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
alpha cell tumor
¾ËÆÄ ¼¼Æ÷Á¾(¡á¬øàðþ)
alpha chain disease
¾ËÆÄ¼âº´(¡áðÜ»).
alpha chain disease
¾ËÆÄ¼âÁúȯ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½